20 modal-time-freqeuncy-artificial-intelligence Postdoctoral positions at University of Virginia
Sort by
Refine Your Search
-
foundation model pipelines Resilience of AI systems Scaling and systems theoretic modeling of generative AI We seek applicants who are eager to push the boundaries of data science, artificial intelligence, and
-
postdoctoral researcher for pioneering research at the convergence of artificial intelligence (AI) and materials science. The ideal candidate should possess expertise in scientific machine learning (SciML
-
We seek applicants who are eager to push the boundaries of data science, artificial intelligence, and network modeling to address real-world policy challenges. Key Responsibilities: The Postdoctoral
-
with mice work is ideal. Responsibilities include: Full-time research or scholarship at the University. Preparatory for a full-time academic or research career. Supervised by a senior scholar, and allows
-
who has been awarded a Ph.D. or equivalent doctorate within the previous five years1 and who will be involved in full-time research or scholarship at the University. Employment as a Postdoctoral
-
settings; randomized controlled trials. Administrative expertise: Proficient with Box, Google Suite, Microsoft Suite (Word, Excel, PowerPoint, Outlook, Teams), Zoom, and ability to learn new statistical
-
, school social work, public health, educational policy or related discipline is required by the start date of the position. Supporting school mental health services, especially in high-need schools
-
awarded a Ph.D. or equivalent doctorate within the previous five years and who will be involved in full-time research or scholarship at the University. Employment as a Postdoctoral Research Associate is
-
The Frank Batten School of Leadership and Public Policy at the University of Virginia invites applications for a full-time postdoctoral research position. The position is offered for one year
-
selective full agonist for the dopamine D1 receptor. We took this project from an idea to clinical trials and showed that it might be the first novel treatment of Parkinson’s disease, an idea proven with